Issn Print: 1522-8517
Publication Date: 2017/05/01
The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria
Lakshmi Nayak; Lisa M. DeAngelis; Alba A. Brandes; David M. Peereboom; Evanthia Galanis; Nancy U. Lin; Riccardo Soffietti; David R. Macdonald; Marc Chamberlain; James Perry; Kurt Jaeckle; Minesh Mehta; Roger Stupp; Alona Muzikansky; Elena Pentsova; Timothy Cloughesy; Fabio M. Iwamoto; Joerg-Christian Tonn; Michael A. Vogelbaum; Patrick Y. Wen; Martin J. van den Bent; David A. Reardon
Author Information: Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts (L.N., P.Y.W., D.A.R.); Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York (L.M.D., E.P.); Department of Medical Oncology, Azienda USL-IRCCS Institute of Neurological Science, Bologna, Italy (A.A.B.); Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (D.M.P., M.A.V.); Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts (N.U.L.); Department of Neurology and Neuro-Oncology, University of Turin, Turin, Italy (R.S.); Department of Oncology, London Health Sciences Centre, University of Western Ontario, London, Ontario, Canada (D.R.M.); Department of Neurology, Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance, University of Washington School of Medicine, Seattle, Washington (M.C.); Division of Neurology, Sunnybrook Health Science Center, University of Toronto, Toronto, Ontario, Canada (J.P.); Department of Neurology and Hematology/Oncology, Mayo Clinic, Jacksonville, Florida (K.J.); Department of Radiation Oncology, Miami Cancer Institute, Miami, Florida (M.M.); Department of Oncology, University of Zurich, Zurich, Switzerland (R.S.); Biostatistics Center, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (A.M.); Neuro-Oncology Program, Ronald Reagan UCLA Medical Center, University of CaliforniaLos Angeles, Los Angeles, California (T.C.); Division of Neuro-Oncology, Neurological Institute of New York College of Physicians and Surgeons, Columbia University, New York, New York (F.M.I.); Department of Neurosurgery, LMU University of Munich, Munich, Germany (J.-C.T.); Neuro-Oncology Unit, Erasmus MC Cancer Center, Erasmus MC, Rotterdam, the Netherlands (M.J.B.)
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.